Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark FitzGerald

Showing results (281-290 of 325) with videos related to

Pageof 33
Sort By:
Respirology (Carlton, Vic.)|February 18, 2020
Identification and definition of asthma-COPD overlap: The CanCOLD studyMiriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, et al.
The European Respiratory Journal|June 29, 2019
GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescentsHelen K Reddel, J Mark FitzGerald, Eric D Bateman, et al.
The Lancet. Respiratory Medicine|May 26, 2018
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRichard J Russell, Latifa Chachi, J Mark FitzGerald, et al.
Science Translational Medicine|July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE productionGail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
Plos One|August 16, 2016
COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass SpectrometryJanice M Leung, Virginia Chen, Zsuzsanna Hollander, et al.
BMJ Open|June 17, 2017
In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique using electronic monitoring improve clinical decision making? A protocol for a randomised controlled trialMatshediso C Mokoka, Lorna Lombard, Elaine M MacHale, et al.
The European Respiratory Journal|February 23, 2023
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthmaGail M Gauvreau, Jens M Hohlfeld, J Mark FitzGerald, et al.
Journal of Asthma and Allergy|November 17, 2021
Impact of Socioeconomic Status on Adult Patients with Asthma: A Population-Based Cohort Study from UK Primary CareJohn Busby, David Price, Riyad Al-Lehebi, et al.
The European Respiratory Journal|July 1, 2017
Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injurySaid Laribi, Chris J Pemberton, Lyndsey Kirwan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 4, 2022
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstructionNicola A Hanania, Mario Castro, Eric Bateman, et al.
Pageof 33

Showing results (281-290 of 325) with videos related to

Sort By:
Pageof 33
Respirology (Carlton, Vic.)|February 18, 2020
Identification and definition of asthma-COPD overlap: The CanCOLD studyMiriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, et al.
The European Respiratory Journal|June 29, 2019
GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescentsHelen K Reddel, J Mark FitzGerald, Eric D Bateman, et al.
The Lancet. Respiratory Medicine|May 26, 2018
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRichard J Russell, Latifa Chachi, J Mark FitzGerald, et al.
Science Translational Medicine|July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE productionGail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
Plos One|August 16, 2016
COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass SpectrometryJanice M Leung, Virginia Chen, Zsuzsanna Hollander, et al.
BMJ Open|June 17, 2017
In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique using electronic monitoring improve clinical decision making? A protocol for a randomised controlled trialMatshediso C Mokoka, Lorna Lombard, Elaine M MacHale, et al.
The European Respiratory Journal|February 23, 2023
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthmaGail M Gauvreau, Jens M Hohlfeld, J Mark FitzGerald, et al.
Journal of Asthma and Allergy|November 17, 2021
Impact of Socioeconomic Status on Adult Patients with Asthma: A Population-Based Cohort Study from UK Primary CareJohn Busby, David Price, Riyad Al-Lehebi, et al.
The European Respiratory Journal|July 1, 2017
Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injurySaid Laribi, Chris J Pemberton, Lyndsey Kirwan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 4, 2022
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstructionNicola A Hanania, Mario Castro, Eric Bateman, et al.
Pageof 33